Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose intravenous growth hormone with glutamine in late-phase critically ill multiple trauma patients
2004-004727-36Phase 3Completed
- Sponsor
- Charles University
- Start
- Jan 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of somatropin in critical illness (2 arms), sponsored by Charles University. Primary endpoint: Nitrogen balance. Started Jan 2005; status: completed.
02
Drugs
somatropin
03
Conditions
critical illness
Beyond the preview
Go deeper on 2004-004727-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004727-36.